文献
J-GLOBAL ID:201202201153576281
整理番号:12A1690854
細胞核因子-κB阻害は分化した甲状腺癌のin vivo治療に与える131Iの治療効果を増加する
Nuclear factor-kappa B inhibition can enhance therapeutic efficacy of 131I on the in vivo management of differentiated thyroid cancer
著者 (8件):
MENG Zhaowei
(Dep. of Nuclear Medicine, Tianjin Medical Univ. General Hospital, Tianjin, P.R. China)
,
LOU Shanshan
(Dep. of Nuclear Medicine, Tianjin Medical Univ. General Hospital, Tianjin, P.R. China)
,
LOU Shanshan
(Tianjin Normal Univ., Tianjin, P.R. China)
,
TAN Jian
(Dep. of Nuclear Medicine, Tianjin Medical Univ. General Hospital, Tianjin, P.R. China)
,
XU Ke
(Tianjin Key Lab. of Lung Cancer Metastasis and Tumor Microenviroment, Tianjin Lung Cancer Inst., Tianjin Medical ...)
,
JIA Qiang
(Dep. of Nuclear Medicine, Tianjin Medical Univ. General Hospital, Tianjin, P.R. China)
,
ZHENG Wei
(Dep. of Nuclear Medicine, Tianjin Medical Univ. General Hospital, Tianjin, P.R. China)
,
WANG Shen
(Dep. of Nuclear Medicine, Tianjin Medical Univ. General Hospital, Tianjin, P.R. China)
資料名:
Life Sciences
(Life Sciences)
巻:
91
号:
23-24
ページ:
1236-1241
発行年:
2012年12月10日
JST資料番号:
B0699B
ISSN:
0024-3205
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)